What are the targeted drugs for kidney cancer

With the development of biological and medical technology, the treatment of kidney cancer has made great progress. Biological treatment has shown good results. Among them, targeted drug treatment is particularly effective and has been used in a certain range of clinics. So what are the targeted drugs for kidney cancer? Let's introduce them to you below.

Targeted drugs for kidney cancer include sorafenib and sunitinib. They are generally more economical. If the pathology shows clear cell carcinoma, molecular targeted therapy can be selected. Molecular targeted therapy, also known as "biological missiles", is designed at the cellular molecular level to target the identified carcinogenic sites to design corresponding therapeutic drugs to kill tumor cells without harming normal tissues.
Targeted drugs for kidney cancer inhibit tumor angiogenesis. In order for a tumor to grow quickly and aggressively, it needs a better supply of nutrients than normal tissues. This nutrition is provided by blood vessels. Under the action of targeted drugs, new blood vessels disappear, or the already grown blood vessels are blocked. Without nutrients, the tumor will stagnate in growth, some may shrink, and a few may even disappear in the end. In general, the mechanism of action of targeted therapy is not killing, but inhibition.